Anoctamin 1 controls bone resorption by coupling Cl− channel activation with RANKL-RANK signaling transduction
Weijia Sun,Shuai Guo,Yuheng Li,JianWei Li,Caizhi Liu,Yafei Chen,Xuzhao Wang,Yingjun Tan,Hua Tian,Cheng Wang,Ruikai Du,Guohui Zhong,Sai Shi,Biao Ma,Chang Qu,Jingxuan Fu,Xiaoyan Jin,Dingsheng Zhao,Yong Zhan,Shukuan Ling,Hailong An,Yingxian Li
DOI: https://doi.org/10.1038/s41467-022-30625-9
IF: 16.6
2022-05-24
Nature Communications
Abstract:Abstract Osteoclast over-activation leads to bone loss and chloride homeostasis is fundamental importance for osteoclast function. The calcium-activated chloride channel Anoctamin 1 (also known as TMEM16A) is an important chloride channel involved in many physiological processes. However, its role in osteoclast remains unresolved. Here, we identified the existence of Anoctamin 1 in osteoclast and show that its expression positively correlates with osteoclast activity. Osteoclast-specific Anoctamin 1 knockout mice exhibit increased bone mass and decreased bone resorption. Mechanistically, Anoctamin 1 deletion increases intracellular Cl − concentration, decreases H + secretion and reduces bone resorption. Notably, Anoctamin 1 physically interacts with RANK and this interaction is dependent upon Anoctamin 1 channel activity, jointly promoting RANKL-induced downstream signaling pathways. Anoctamin 1 protein levels are substantially increased in osteoporosis patients and this closely correlates with osteoclast activity. Finally, Anoctamin 1 deletion significantly alleviates ovariectomy induced osteoporosis. These results collectively establish Anoctamin 1 as an essential regulator in osteoclast function and suggest a potential therapeutic target for osteoporosis.
multidisciplinary sciences